Cytochrome P450-dependent metabolism of midazolam in hepatic microsomes from chickens, turkeys, pheasant and bobwhite quail

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2006, Pages 469-476

  Cortright, K A ^a,b   Craigmill, A L ^b  

^a Department of Environmental Toxicology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYMIDAZOLAM; 4 HYDROXYMIDAZOLAM; CLONAZEPAM; CYTOCHROME P450 3A; DRUG METABOLITE; ENZYME INHIBITOR; KETOCONAZOLE; MIDAZOLAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; QUAIL; TURKEY (BIRD);

ANIMALS; ANTI-ANXIETY AGENTS; ANTIFUNGAL AGENTS; BIRDS; CHICKENS; CYTOCHROME P-450 CYP3A; INHIBITORY CONCENTRATION 50; KETOCONAZOLE; MICROSOMES, LIVER; MIDAZOLAM; QUAIL; SPECIES SPECIFICITY; TURKEYS;

AVES; COLINUS VIRGINIANUS; GALLUS GALLUS;

EID: 33750583564     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00793.x     Document Type: Article

References (41)

1. Amsallem-Holtzman, E. & Ben-Zvi, Z. (1997) Drug metabolizing enzymes in the ostrich (Struthio camelus): comparison with the chicken and rat. Comparative Biochemistry and Physiology C, 116, 47-50.
2. Baldwin, S.J., Bloomer, J.C., Smith, G.J., Ayrton, A.D., Clarke, S.E. & Chenery, R.J. (1995) Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica, 25, 261-270.
3. Boyd, M.R., Burka, L.T., Wilson, B.J. & Sasame, H.A. (1978) In vitro studies on the metabolic activity of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes. The Journal of Pharmacology and Experimental Therapeutics, 207, 677-686.
4. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
5. Cornish-Bowden, A. (1995) Fundamentals of Enzyme Kinetics. Portland Press Ltd, London.
6. Coulet, M., Eeckhoutte, C. & Galtier, P. (1996) Ontogenic development of drug-metabolizing enzymes in male chicken liver. Canadian Journal of Physiology and Pharmacology, 74, 32-37.
7. Dalvi, R.R., Nunn, V.A. & Juskevich, J. (1987) Studies on comparative drug metabolism by hepatic cytochrome P450-containing microsomal enzymes in quail, ducks, geese, chickens, turkeys and rats. Comparative Biochemistry and Physiology C, 87, 421-424.
8. Day, T.K. & Roge, C.K. (1996) Evaluation of sedation in quail induced by use of midazolam and reversed by use of flumazenil. Journal of the American Veterinary Medical Association, 209, 969-971.
9. Day, K., Reynolds, J.D., Morin, D.R., Plopper, C.G. & Fanucchi, M.V. (2005) Role of Pulmonary Cytochrome P450 3A1 in 1-Nitronaphthalene Bioactivation and Injury in Adult and Postnatal Rats. Abstract 359, The Toxicologist CD - An official Journal of the Society of Toxicology, Volume 84, Number S-1, March 2005.
10. Domanski, T.L., He, Y., Harlow, G.R. & Halpert, J.R. (2000) Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity. The Journal of Pharmacology and Experimental Therapeutics, 293, 585-591.
11. Ette, E. & Williams, P. (2004) Population pharmacokinetics II: estimation methods. The Annals of Pharmacotherapy, 38, 1907-1915.
12. Forbes, N.A. (1998) Avian anesthesia. Veterinary Quarterly, 20, S65-66.
13. Ghosal, A., Satoh, H., Thomas, P.E., Bush, E. & Moore, D. (1996) Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450. Drug Metabolism and Disposition, 24, 940-947.
14. Gibbs, M.A., Kunze, K.L., Howald, W.N. & Thummel, K.E. (1999a) Effect of inhibitor depletion on inhibitory potency: tight binding inhibition of CYP3A by clotrimazole. Drug Metabolism and Disposition, 27, 596-599.
15. i values and impact of CYP3A5 expression. Drug Metabolism and Disposition, 27, 180-187.
16. Giorgi, M., Marini, S., Longo, V., Mazzaccaro, A., Amato, G. & Gervasi, P.G. (2000) Cytochrome P450-dependent monooxygenase activities and their inducibility by classic P450 inducers in the liver, kidney, and nasal mucosa of male adult ring-necked pheasants. Toxicology and Applied Pharmacology, 167, 237-245.
17. Gorski, J., Hall, S., Jones, D., VandenBranden, M. & Wrighton, S. (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochemical Pharmacology, 47, 1643-1653.
18. Hamaoka, N., Oda, Y., Hase, I. & Asada, A. (2001) Cytochrome P450B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. British Journal of Anaesthesia, 86, 540-544.
19. Hardman, J.G. (Ed.) (2001) Goodman & Gilman's the Pharmacological Basis of Therapeutics. McGraw-HiIl, New York.
20. Heizmann, P. & Ziegler, W.H. (1981) Excretion and metabolism of 14C-midazolam in humans following oral dosing. Arzneimittel-Forschung, 31, 2220-2223.
21. Hillier, L.W., Miller, W., Birney, E., Warren, W., Hardison, R., Ponting, C., Bork, P., Burt, D., Groenen, M. & Delany, M. (2004) Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature, 432, 695-716.
22. Houston, B.J. & Kenworthy, K.E. (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menton model. Drug Metabolism and Disposition, 28, 246-254.
23. Khalil, W.F., Saitoh, T., Shimoda, M. & Kokue, E. (2001) In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens. Journal of Veterinary Pharmacology and Therapeutics, 24, 343-348.
24. Khan, K.K., He, Y.Q., Domanski, T.L. & Halpert, J.R. (2002) Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation. Molecular Pharmaceutics, 61, 495-506.
25. Klein, P.J., Buckner, R., Kelly, J. & Coulombe, R.A. (2000) Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B1. Toxicology and Applied Pharmacology, 165, 45-52.
26. Kobayashi, K., Urashima, K., Shimada, N. & Chiba, K. (2002) Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology, 63, 889-896.
27. Kobayashi, K., Urashima, K., Shimada, N. & Chiba, K. (2003) Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Drug Metabolism and Disposition, 31, 833-836.
28. Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F.J. & Meyer, U.A. (1989) Oxidation of Midazolam and Triazolam by human liver cytochrome P4503A4. Molecular Pharmaceutics, 36, 89-96.
29. Kuroha, M., Kuze, Y., Shimoda, M. & Kokue, E. (2002) In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes. American Journal of Veterinary Research, 63, 900-905.
30. Lorr, N.A., Bloom, S.E., Park, S.S., Gelboin, H.V., Miller, H. & Friedman, F.K. (1989) Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms. Molecular Pharmaceutics, 35, 610-616.
31. Machin, K.L. & Caulkett, N.A. (1998) Investigation of injectabile anesthetic agents in Mallard ducks (Anas platyrhynchos): a descriptive study. Journal of Avian Medicine and Surgery, 12, 255-262.
32. Nebbia, C., Ceppa, L., Dacasto, M., Nachtmann, C. & Carletti, M. (2001) Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. Journal of Veterinary Pharmacology and Therapeutics, 24, 399-403.
33. Olkowski, A., Gooneratne, R. & Eason, C. (1998) Cytochrome P450 enzyme activities in the australian brushtail possum trichosurus vulpesula: a comparison with the rat, rabbit, sheep and chicken. Veterinary and Human Toxicology, 40, 70-76.
34. Omura, T. & Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370-2385.
35. Ourlin, J., Baader, M., Fraser, D., Halpert, J. & Meyer, U.A. (2000) Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37). Archives of Biochemistry and Biophysics, 373, 375-384.
36. Perloff, M.D., Von Moltke, L.L., Court, M.H., Kotegawa, T., Shader, R.I. & Greenblatt, D.J. (2000) Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. The Journal of Pharmacology and Experimental Therapeutics, 292, 618-628.
37. Ronis, M.J.J., Ingelman-Sundberg, M. & Badger, T.M. (1994) Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochemical Pharmacology, 48, 1953-1965.
38. Ronis, M.J.J., Celander, M. & Badger, T.M. (1998) Cytochrome P450 enzymes in the kidney of the bobwhite quail (Colinus virginianus): induction and inhibition by ergosterol biosynthesis inhibiting fungicides. Comparative Biochemistry and Physiology C, 121, 221-229.
39. Segel, I.H. (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley and Sons, Inc., New York.
40. Sharer, J.E., Shipley, L.A., VandenBranden, M.R., Binkley, S.N. & Wrighton, S. (1995) Comparisons of Phase I and Phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231-1241.
41. Wrighton, S.A. & Ring, B.J. (1994) Inhibition of human CYP3A catalyzed 1′-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharmaceutical Research, 11, 921-924.